Guides
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on IDT Australia.
RELATED STOCKHEAD STORIES
Health & Biotech
Check up: Making it in America
News
Lunchtime ASX Small Cap Wrap: Who wants to hear the good news today?
Health & Biotech
Bard1 makes Sienna an offer it can’t refuse: a $45m merger
News
This is what being on a ‘war footing’ against COVID-19 looks like
Health & Biotech
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
News
Lunchtime ASX small cap wrap: Who’s on the throne today?
Health & Biotech
Cannabis: Cann-made marijuana resin could be on the market by March
News
10 at 10: These ASX stocks are looking Golden Globe-worthy this morning
News
Here’s the bad news some ASX small caps tried to slip past you over Christmas
Health & Biotech
Health: Invion may have found its break in Chinese dermatology
Health & Biotech
Cannabis: Cann Global is entering the African cannabis market
News
Weed Week: Statisticians have figured out who’s smoking the most pot in Canada
Health & Biotech
Health: Orthocell has done it again as patients regain shoulder function following CelGro surgery
Health & Biotech
Weed Week: G-men getting on the hype train
News
Weed Week: Which of you were forced to sell your beloved pot stocks last week?
Health & Biotech
Cannabis: Cann is Australia’s pot king after scoring a manufacturing licence through IDT
Health & Biotech
